Handelsbanken Fonder’s Celgene Corp CELG Stock Holding History

Handelsbanken Fonder’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-130,000	Closed	-$12.3M	–	199
2019 Q1	$12.3M	Buy	+130,000	New	+$11.4M	0.24%	111
2018 Q4	–	Sell	-541,609	Closed	-$48.5M	–	191
2018 Q3	$48.5M	Buy	541,609 +65,160	+14%	+$5.76M	0.91%	38
2018 Q2	$37.8M	Sell	476,449 -1,000	-0.2%	-$83K	0.74%	48
2018 Q1	$42.6M	Buy	477,449 +4,000	+0.8%	+$384K	0.83%	44
2017 Q4	$49.4M	Sell	473,449 -29,500	-6%	-$3.33M	1.08%	29
2017 Q3	$73.3M	Buy	502,949 +16,500	+3%	+$2.25M	1.7%	13
2017 Q2	$63.2M	Buy	486,449 +42,000	+9%	+$5.15M	1.61%	19
2017 Q1	$55.3M	Buy	444,449 +3,000	+0.7%	+$359K	1.54%	19
2016 Q4	$51.1M	Buy	441,449 +55,500	+14%	+$6.18M	1.56%	16
2016 Q3	$40.3M	Buy	385,949 +16,639	+5%	+$1.8M	1.18%	24
2016 Q2	$36.4M	Buy	369,310 +14,000	+4%	+$1.45M	1.49%	18
2016 Q1	$35.6M	Sell	355,310 -100,028	-22%	-$10.3M	1.52%	19
2015 Q4	$54.5M	Buy	+455,338	New	+$52.7M	1.05%	14

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Handelsbanken Fonder's CELG Position: Q2 2019 in Review

Handelsbanken Fonder sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 130,000 shares — an estimated $12.3M sold.

Handelsbanken Fonder first reported a position in CELG in Q4 2015 and held it in 13 quarters. The position peaked at $73.3M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Handelsbanken Fonder reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Handelsbanken Fonder sold 130,000 Celgene Corp shares in Q2 2019, an estimated $12.3M.
Handelsbanken Fonder first reported a position in Celgene Corp in Q4 2015 and held it in 13 quarters.
Handelsbanken Fonder's Celgene Corp position peaked at $73.3M in Q3 2017.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Handelsbanken Fonder's 13F filing for Q2 2019, filed 12 Jul 2019.